Page last updated: 2024-08-07 17:32:52
Histamine H3 receptor
A histamine H3 receptor that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q9Y5N1]
Synonyms
H3R;
HH3R;
G-protein coupled receptor 97
Research
Bioassay Publications (149)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 57 (38.26) | 29.6817 |
2010's | 75 (50.34) | 24.3611 |
2020's | 17 (11.41) | 2.80 |
Compounds (75)
Drugs with Inhibition Measurements
Drugs with Activation Measurements
Drugs with Other Measurements
A Versatile Sub-Nanomolar Fluorescent Ligand Enables NanoBRET Binding Studies and Single-Molecule Microscopy at the Histamine HJournal of medicinal chemistry, , 08-12, Volume: 64, Issue:15, 2021
Pharmacological characterization of a new series of carbamoylguanidines reveals potent agonism at the HEuropean journal of medicinal chemistry, , Mar-15, Volume: 214, 2021
[no title available]Bioorganic & medicinal chemistry, , 01-15, Volume: 30, 2021
[no title available]Journal of medicinal chemistry, , 06-24, Volume: 64, Issue:12, 2021
Novel pyrrolidinone derivative lacks claimed histamine HEuropean journal of medicinal chemistry, , Apr-01, Volume: 191, 2020
[no title available]Journal of medicinal chemistry, , 12-12, Volume: 62, Issue:23, 2019
Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.Journal of medicinal chemistry, , Apr-14, Volume: 59, Issue:7, 2016
Synthesis and evaluation of a 2-benzothiazolylphenylmethyl ether class of histamine H4 receptor antagonists.Bioorganic & medicinal chemistry letters, , 11-01, Volume: 26, Issue:21, 2016
Functional Profiling of 2-Aminopyrimidine Histamine H4 Receptor Modulators.Journal of medicinal chemistry, , Sep-24, Volume: 58, Issue:18, 2015
Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.Journal of medicinal chemistry, , Dec-08, Volume: 54, Issue:23, 2011
Triazole ligands reveal distinct molecular features that induce histamine H4 receptor affinity and subtly govern H4/H3 subtype selectivity.Journal of medicinal chemistry, , Mar-24, Volume: 54, Issue:6, 2011
Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivity.Bioorganic & medicinal chemistry letters, , May-15, Volume: 20, Issue:10, 2010
Role of hydrophobic substituents on the terminal nitrogen of histamine in receptor binding and agonist activity: development of an orally active histamine type 3 receptor agonist and evaluation of its antistress activity in mice.Journal of medicinal chemistry, , May-13, Volume: 53, Issue:9, 2010
Histamine H4 receptor agonists.Bioorganic & medicinal chemistry letters, , Dec-15, Volume: 20, Issue:24, 2010
N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.Journal of medicinal chemistry, , Apr-23, Volume: 52, Issue:8, 2009
Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.Journal of medicinal chemistry, , Nov-27, Volume: 51, Issue:22, 2008
Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.Journal of medicinal chemistry, , Sep-07, Volume: 49, Issue:18, 2006
Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.The Journal of pharmacology and experimental therapeutics, , Volume: 314, Issue:3, 2005
Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.Journal of medicinal chemistry, , May-08, Volume: 46, Issue:10, 2003
A selective human H(4)-receptor agonist: (-)-2-cyano-1-methyl-3-[(2R,5R)-5- [1H-imidazol-4(5)-yl]tetrahydrofuran-2-y] methylguanidine.Journal of medicinal chemistry, , Jul-03, Volume: 46, Issue:14, 2003
Synthesis and structure-activity relationships of conformationally constrained histamine H(3) receptor agonists.Journal of medicinal chemistry, , Dec-04, Volume: 46, Issue:25, 2003
Histamine H4 receptor agonists.Bioorganic & medicinal chemistry letters, , Dec-15, Volume: 20, Issue:24, 2010
Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.The Journal of pharmacology and experimental therapeutics, , Volume: 314, Issue:3, 2005
The discovery of quinoline based single-ligand human HBioorganic & medicinal chemistry letters, , 12-15, Volume: 26, Issue:24, 2016
Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.Bioorganic & medicinal chemistry, , Oct-15, Volume: 20, Issue:20, 2012
The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.Journal of medicinal chemistry, , Apr-14, Volume: 54, Issue:7, 2011
[no title available]Journal of medicinal chemistry, , 06-23, Volume: 65, Issue:12, 2022
A Versatile Sub-Nanomolar Fluorescent Ligand Enables NanoBRET Binding Studies and Single-Molecule Microscopy at the Histamine HJournal of medicinal chemistry, , 08-12, Volume: 64, Issue:15, 2021
[no title available]European journal of medicinal chemistry, , Feb-15, Volume: 212, 2021
Structural modifications in the distal, regulatory region of histamine HEuropean journal of medicinal chemistry, , Mar-05, Volume: 213, 2021
[no title available]Bioorganic & medicinal chemistry, , 08-15, Volume: 44, 2021
[no title available]Journal of medicinal chemistry, , 05-28, Volume: 63, Issue:10, 2020
Synthesis and evaluation of N-alkyl-S-[3-(piperidin-1-yl)propyl]isothioureas: high affinity and human/rat species-selective histamine H(3) receptor antagonists.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 23, Issue:23, 2013
N-Alkenyl and cycloalkyl carbamates as dual acting histamine H3 and H4 receptor ligands.Bioorganic & medicinal chemistry, , May-01, Volume: 19, Issue:9, 2011
Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.Journal of medicinal chemistry, , Dec-08, Volume: 54, Issue:23, 2011
Investigation of 4-piperidinols as novel H3 antagonists.Bioorganic & medicinal chemistry letters, , Nov-01, Volume: 20, Issue:21, 2010
Clobenpropit analogs as dual activity ligands for the histamine H3 and H4 receptors: synthesis, pharmacological evaluation, and cross-target QSAR studies.Bioorganic & medicinal chemistry, , Jun-01, Volume: 17, Issue:11, 2009
Histamine H3 and H4 receptor affinity of branched 3-(1H-imidazol-4-yl)propyl N-alkylcarbamates.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 19, Issue:23, 2009
4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists.Journal of medicinal chemistry, , May-22, Volume: 51, Issue:10, 2008
Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.The Journal of pharmacology and experimental therapeutics, , Volume: 314, Issue:3, 2005
2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists.Journal of medicinal chemistry, , Jan-13, Volume: 48, Issue:1, 2005
1-alkyl-4-acylpiperazines as a new class of imidazole-free histamine H(3) receptor antagonists.Journal of medicinal chemistry, , May-20, Volume: 47, Issue:11, 2004
Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.Journal of medicinal chemistry, , Apr-10, Volume: 46, Issue:8, 2003
Different antagonist binding properties of human and rat histamine H3 receptors.Bioorganic & medicinal chemistry letters, , Apr-09, Volume: 11, Issue:7, 2001
Novel naphthyridines are histamine H3 antagonists and serotonin reuptake transporter inhibitors.Bioorganic & medicinal chemistry letters, , May-01, Volume: 17, Issue:9, 2007
Dual serotonin transporter/histamine H3 ligands: Optimization of the H3 pharmacophore.Bioorganic & medicinal chemistry letters, , Feb-01, Volume: 17, Issue:3, 2007
Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 17, Issue:4, 2007
Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.Bioorganic & medicinal chemistry letters, , Sep-01, Volume: 17, Issue:17, 2007
A Versatile Sub-Nanomolar Fluorescent Ligand Enables NanoBRET Binding Studies and Single-Molecule Microscopy at the Histamine HJournal of medicinal chemistry, , 08-12, Volume: 64, Issue:15, 2021
Novel pyrrolidinone derivative lacks claimed histamine HEuropean journal of medicinal chemistry, , Apr-01, Volume: 191, 2020
Discovery and Development of N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide Dihydrochloride (SUVN-G3031): A Novel, Potent, Selective, and Orally Active Histamine HJournal of medicinal chemistry, , 02-14, Volume: 62, Issue:3, 2019
N-Alkenyl and cycloalkyl carbamates as dual acting histamine H3 and H4 receptor ligands.Bioorganic & medicinal chemistry, , May-01, Volume: 19, Issue:9, 2011
Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.Journal of medicinal chemistry, , Dec-08, Volume: 54, Issue:23, 2011
Role of hydrophobic substituents on the terminal nitrogen of histamine in receptor binding and agonist activity: development of an orally active histamine type 3 receptor agonist and evaluation of its antistress activity in mice.Journal of medicinal chemistry, , May-13, Volume: 53, Issue:9, 2010
Histamine H4 receptor agonists.Bioorganic & medicinal chemistry letters, , Dec-15, Volume: 20, Issue:24, 2010
Clobenpropit analogs as dual activity ligands for the histamine H3 and H4 receptors: synthesis, pharmacological evaluation, and cross-target QSAR studies.Bioorganic & medicinal chemistry, , Jun-01, Volume: 17, Issue:11, 2009
Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.The Journal of pharmacology and experimental therapeutics, , Volume: 314, Issue:3, 2005
Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.Journal of medicinal chemistry, , May-08, Volume: 46, Issue:10, 2003
Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.Journal of medicinal chemistry, , Apr-14, Volume: 59, Issue:7, 2016
Histamine H4 receptor agonists.Bioorganic & medicinal chemistry letters, , Dec-15, Volume: 20, Issue:24, 2010
Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.The Journal of pharmacology and experimental therapeutics, , Volume: 314, Issue:3, 2005
The first potent and selective non-imidazole human histamine H4 receptor antagonists.Journal of medicinal chemistry, , Sep-11, Volume: 46, Issue:19, 2003
Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.Journal of medicinal chemistry, , Dec-08, Volume: 54, Issue:23, 2011
Histamine H4 receptor agonists.Bioorganic & medicinal chemistry letters, , Dec-15, Volume: 20, Issue:24, 2010
Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.The Journal of pharmacology and experimental therapeutics, , Volume: 314, Issue:3, 2005
Different antagonist binding properties of human and rat histamine H3 receptors.Bioorganic & medicinal chemistry letters, , Apr-09, Volume: 11, Issue:7, 2001
A Versatile Sub-Nanomolar Fluorescent Ligand Enables NanoBRET Binding Studies and Single-Molecule Microscopy at the Histamine HJournal of medicinal chemistry, , 08-12, Volume: 64, Issue:15, 2021
Novel pyrrolidinone derivative lacks claimed histamine HEuropean journal of medicinal chemistry, , Apr-01, Volume: 191, 2020
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.Bioorganic & medicinal chemistry letters, , Mar-15, Volume: 23, Issue:6, 2013
Role of hydrophobic substituents on the terminal nitrogen of histamine in receptor binding and agonist activity: development of an orally active histamine type 3 receptor agonist and evaluation of its antistress activity in mice.Journal of medicinal chemistry, , May-13, Volume: 53, Issue:9, 2010
Histamine H4 receptor agonists.Bioorganic & medicinal chemistry letters, , Dec-15, Volume: 20, Issue:24, 2010
Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists.European journal of medicinal chemistry, , Volume: 44, Issue:11, 2009
4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists.Journal of medicinal chemistry, , May-22, Volume: 51, Issue:10, 2008
Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.The Journal of pharmacology and experimental therapeutics, , Volume: 314, Issue:3, 2005
1-alkyl-4-acylpiperazines as a new class of imidazole-free histamine H(3) receptor antagonists.Journal of medicinal chemistry, , May-20, Volume: 47, Issue:11, 2004
The first potent and selective non-imidazole human histamine H4 receptor antagonists.Journal of medicinal chemistry, , Sep-11, Volume: 46, Issue:19, 2003
Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.Journal of medicinal chemistry, , May-08, Volume: 46, Issue:10, 2003
Synthesis and structure-activity relationships of conformationally constrained histamine H(3) receptor agonists.Journal of medicinal chemistry, , Dec-04, Volume: 46, Issue:25, 2003
Histamine H4 receptor agonists.Bioorganic & medicinal chemistry letters, , Dec-15, Volume: 20, Issue:24, 2010
Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.The Journal of pharmacology and experimental therapeutics, , Volume: 314, Issue:3, 2005
Synthesis and structure-activity relationships of conformationally constrained histamine H(3) receptor agonists.Journal of medicinal chemistry, , Dec-04, Volume: 46, Issue:25, 2003
Nature-inspired pyrrolo[2,3-d]pyrimidines targeting the histamine HBioorganic & medicinal chemistry, , 07-15, Volume: 27, Issue:14, 2019
Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists.European journal of medicinal chemistry, , Volume: 44, Issue:11, 2009
Aplysamine-1 and related analogs as histamine H3 receptor antagonists.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 16, Issue:4, 2006
Design of a new histamine H3 receptor antagonist chemotype: (3aR,6aR)-5-alkyl-1-aryl-octahydropyrrolo[3,4-b]pyrroles, synthesis, and structure-activity relationships.Journal of medicinal chemistry, , Aug-13, Volume: 52, Issue:15, 2009
Piperidine variations in search for non-imidazole histamine H(3) receptor ligands.Bioorganic & medicinal chemistry, , Sep-15, Volume: 16, Issue:18, 2008
The alkaloid conessine and analogues as potent histamine H3 receptor antagonists.Journal of medicinal chemistry, , Sep-11, Volume: 51, Issue:17, 2008
Histamine HBioorganic & medicinal chemistry, , 11-15, Volume: 50, 2021
Structural modifications in the distal, regulatory region of histamine HEuropean journal of medicinal chemistry, , Mar-05, Volume: 213, 2021
A Versatile Sub-Nanomolar Fluorescent Ligand Enables NanoBRET Binding Studies and Single-Molecule Microscopy at the Histamine HJournal of medicinal chemistry, , 08-12, Volume: 64, Issue:15, 2021
Benzylpiperidine variations on histamine H3 receptor ligands for improved drug-likeness.Bioorganic & medicinal chemistry letters, , May-15, Volume: 24, Issue:10, 2014
Non-imidazole histamine HMedicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 22, Issue:8, 2013
Radiofluorinated histamine H₃ receptor antagonist as a potential probe for in vivo PET imaging: radiosynthesis and pharmacological evaluation.Bioorganic & medicinal chemistry, , May-01, Volume: 20, Issue:9, 2012
Histamine H3 receptor as a drug discovery target.Journal of medicinal chemistry, , Jan-13, Volume: 54, Issue:1, 2011
Novel and highly potent histamine H3 receptor ligands. Part 2: exploring the cyclohexylamine-based series.Bioorganic & medicinal chemistry letters, , Sep-15, Volume: 21, Issue:18, 2011
Acidic elements in histamine H(3) receptor antagonists.Bioorganic & medicinal chemistry letters, , Mar-01, Volume: 20, Issue:5, 2010
Novel substituted pyrrolidines are high affinity histamine H3 receptor antagonists.Bioorganic & medicinal chemistry letters, , May-01, Volume: 20, Issue:9, 2010
Indole- and benzothiophene-based histamine H3 antagonists.Bioorganic & medicinal chemistry letters, , Nov-01, Volume: 20, Issue:21, 2010
5-hydroxyindole-2-carboxylic acid amides: novel histamine-3 receptor inverse agonists for the treatment of obesity.Journal of medicinal chemistry, , Jul-09, Volume: 52, Issue:13, 2009
Fluorinated non-imidazole histamine H3 receptor antagonists.Bioorganic & medicinal chemistry letters, , Apr-15, Volume: 19, Issue:8, 2009
Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists.European journal of medicinal chemistry, , Volume: 44, Issue:11, 2009
2-Aryloxymethylmorpholine histamine H(3) antagonists.Bioorganic & medicinal chemistry letters, , Nov-01, Volume: 18, Issue:21, 2008
Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modeling.Bioorganic & medicinal chemistry, , Mar-15, Volume: 16, Issue:6, 2008
Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.Bioorganic & medicinal chemistry letters, , Apr-01, Volume: 18, Issue:7, 2008
A new class of histamine H3 receptor antagonists derived from ligand based design.Bioorganic & medicinal chemistry letters, , Jul-01, Volume: 17, Issue:13, 2007
4-[6-(2-Aminoethyl)naphthalen-2-yl]benzonitriles are potent histamine H3 receptor antagonists with high CNS penetration.Bioorganic & medicinal chemistry letters, , Mar-01, Volume: 17, Issue:5, 2007
Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.Bioorganic & medicinal chemistry letters, , Sep-01, Volume: 17, Issue:17, 2007
Aplysamine-1 and related analogs as histamine H3 receptor antagonists.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 16, Issue:4, 2006
4-phenoxypiperidines: potent, conformationally restricted, non-imidazole histamine H3 antagonists.Journal of medicinal chemistry, , Mar-24, Volume: 48, Issue:6, 2005
2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists.Journal of medicinal chemistry, , Jan-13, Volume: 48, Issue:1, 2005
A new class of diamine-based human histamine H3 receptor antagonists: 4-(aminoalkoxy)benzylamines.Journal of medicinal chemistry, , Aug-28, Volume: 46, Issue:18, 2003
Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.The Journal of pharmacology and experimental therapeutics, , Volume: 314, Issue:3, 2005
The first potent and selective non-imidazole human histamine H4 receptor antagonists.Journal of medicinal chemistry, , Sep-11, Volume: 46, Issue:19, 2003
Tactical Approaches to Interconverting GPCR Agonists and Antagonists.Journal of medicinal chemistry, , Feb-11, Volume: 59, Issue:3, 2016
Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.Journal of medicinal chemistry, , Dec-08, Volume: 54, Issue:23, 2011
Synthesis and structure-activity relationships of N-aryl-piperidine derivatives as potent (partial) agonists for human histamine H3 receptor.Bioorganic & medicinal chemistry, , Jul-15, Volume: 18, Issue:14, 2010
Histamine H4 receptor agonists.Bioorganic & medicinal chemistry letters, , Dec-15, Volume: 20, Issue:24, 2010
Investigation of the histamine H3 receptor binding site. Design and synthesis of hybrid agonists with a lipophilic side chain.Journal of medicinal chemistry, , Sep-09, Volume: 53, Issue:17, 2010
4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists.Journal of medicinal chemistry, , May-22, Volume: 51, Issue:10, 2008
Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.The Journal of pharmacology and experimental therapeutics, , Volume: 314, Issue:3, 2005
N-substituted piperidinyl alkyl imidazoles: discovery of methimepip as a potent and selective histamine H3 receptor agonist.Journal of medicinal chemistry, , Mar-24, Volume: 48, Issue:6, 2005
Identification of 4-(1H-imidazol-4(5)-ylmethyl)pyridine (immethridine) as a novel, potent, and highly selective histamine H(3) receptor agonist.Journal of medicinal chemistry, , May-06, Volume: 47, Issue:10, 2004
Synthesis and structure-activity relationships of conformationally constrained histamine H(3) receptor agonists.Journal of medicinal chemistry, , Dec-04, Volume: 46, Issue:25, 2003
A Versatile Sub-Nanomolar Fluorescent Ligand Enables NanoBRET Binding Studies and Single-Molecule Microscopy at the Histamine HJournal of medicinal chemistry, , 08-12, Volume: 64, Issue:15, 2021
Structural modifications in the distal, regulatory region of histamine HEuropean journal of medicinal chemistry, , Mar-05, Volume: 213, 2021
[no title available]Journal of medicinal chemistry, , 05-28, Volume: 63, Issue:10, 2020
Discovery and Development of N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide Dihydrochloride (SUVN-G3031): A Novel, Potent, Selective, and Orally Active Histamine HJournal of medicinal chemistry, , 02-14, Volume: 62, Issue:3, 2019
Design, synthesis, and MedChemComm, , Feb-01, Volume: 10, Issue:2, 2019
Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer's disease.European journal of medicinal chemistry, , Apr-15, Volume: 168, 2019
[no title available]Bioorganic & medicinal chemistry, , 05-15, Volume: 26, Issue:9, 2018
Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.Journal of medicinal chemistry, , Apr-14, Volume: 59, Issue:7, 2016
Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties.European journal of medicinal chemistry, , Apr-22, Volume: 77, 2014
Design and synthesis of novel 3-substituted-indole derivatives as selective H3 receptor antagonists and potent free radical scavengers.Bioorganic & medicinal chemistry, , Oct-01, Volume: 21, Issue:19, 2013
Anticonvulsant properties of histamine H3 receptor ligands belonging to N-substituted carbamates of imidazopropanol.Bioorganic & medicinal chemistry letters, , Sep-01, Volume: 23, Issue:17, 2013
N-Alkenyl and cycloalkyl carbamates as dual acting histamine H3 and H4 receptor ligands.Bioorganic & medicinal chemistry, , May-01, Volume: 19, Issue:9, 2011
Histamine H3 receptor as a drug discovery target.Journal of medicinal chemistry, , Jan-13, Volume: 54, Issue:1, 2011
Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H₃R and BACE 1 inhibitory activities.Bioorganic & medicinal chemistry, , Dec-01, Volume: 19, Issue:23, 2011
Triazole ligands reveal distinct molecular features that induce histamine H4 receptor affinity and subtly govern H4/H3 subtype selectivity.Journal of medicinal chemistry, , Mar-24, Volume: 54, Issue:6, 2011
Investigation of the bioactive conformation of histamine H3 receptor antagonists by the cyclopropylic strain-based conformational restriction strategy.Journal of medicinal chemistry, , May-13, Volume: 53, Issue:9, 2010
Clobenpropit analogs as dual activity ligands for the histamine H3 and H4 receptors: synthesis, pharmacological evaluation, and cross-target QSAR studies.Bioorganic & medicinal chemistry, , Jun-01, Volume: 17, Issue:11, 2009
N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.Journal of medicinal chemistry, , Apr-23, Volume: 52, Issue:8, 2009
Histamine H3 and H4 receptor affinity of branched 3-(1H-imidazol-4-yl)propyl N-alkylcarbamates.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 19, Issue:23, 2009
2,4-Diaminopyrimidines as histamine H4 receptor ligands--Scaffold optimization and pharmacological characterization.Bioorganic & medicinal chemistry, , Oct-15, Volume: 17, Issue:20, 2009
Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists.European journal of medicinal chemistry, , Volume: 44, Issue:11, 2009
Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.European journal of medicinal chemistry, , Volume: 44, Issue:10, 2009
The alkaloid conessine and analogues as potent histamine H3 receptor antagonists.Journal of medicinal chemistry, , Sep-11, Volume: 51, Issue:17, 2008
Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.Journal of medicinal chemistry, , Sep-07, Volume: 49, Issue:18, 2006
Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.The Journal of pharmacology and experimental therapeutics, , Volume: 314, Issue:3, 2005
4-phenoxypiperidines: potent, conformationally restricted, non-imidazole histamine H3 antagonists.Journal of medicinal chemistry, , Mar-24, Volume: 48, Issue:6, 2005
4-(2-[2-(2(R)-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and related 2-aminoethylbenzofuran H3 receptor antagonists potently enhance cognition and attention.Journal of medicinal chemistry, , Jan-13, Volume: 48, Issue:1, 2005
2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists.Journal of medicinal chemistry, , Jan-13, Volume: 48, Issue:1, 2005
1-alkyl-4-acylpiperazines as a new class of imidazole-free histamine H(3) receptor antagonists.Journal of medicinal chemistry, , May-20, Volume: 47, Issue:11, 2004
The first potent and selective non-imidazole human histamine H4 receptor antagonists.Journal of medicinal chemistry, , Sep-11, Volume: 46, Issue:19, 2003
Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.Journal of medicinal chemistry, , Apr-10, Volume: 46, Issue:8, 2003
Different antagonist binding properties of human and rat histamine H3 receptors.Bioorganic & medicinal chemistry letters, , Apr-09, Volume: 11, Issue:7, 2001
Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.Journal of medicinal chemistry, , Dec-08, Volume: 54, Issue:23, 2011
Histamine H4 receptor agonists.Bioorganic & medicinal chemistry letters, , Dec-15, Volume: 20, Issue:24, 2010
Discovery of a Novel Highly Selective Histamine H4 Receptor Antagonist for the Treatment of Atopic Dermatitis.Journal of medicinal chemistry, , 04-12, Volume: 61, Issue:7, 2018
Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.Journal of medicinal chemistry, , Apr-14, Volume: 59, Issue:7, 2016
Synthesis of novel histamine H4 receptor antagonists.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 22, Issue:2, 2012
Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.Journal of medicinal chemistry, , Dec-08, Volume: 54, Issue:23, 2011
Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands.Journal of medicinal chemistry, , Oct-23, Volume: 51, Issue:20, 2008
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.Journal of medicinal chemistry, , Nov-27, Volume: 51, Issue:22, 2008
Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.The Journal of pharmacology and experimental therapeutics, , Volume: 314, Issue:3, 2005
Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonists.Journal of medicinal chemistry, , Dec-29, Volume: 48, Issue:26, 2005
A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties.The Journal of pharmacology and experimental therapeutics, , Volume: 309, Issue:1, 2004
Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H(4) receptor antagonists.Bioorganic & medicinal chemistry letters, , Nov-01, Volume: 14, Issue:21, 2004
Histamine H4 receptor agonists.Bioorganic & medicinal chemistry letters, , Dec-15, Volume: 20, Issue:24, 2010
Piperidine variations in search for non-imidazole histamine H(3) receptor ligands.Bioorganic & medicinal chemistry, , Sep-15, Volume: 16, Issue:18, 2008
Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.The Journal of pharmacology and experimental therapeutics, , Volume: 314, Issue:3, 2005
Different antagonist binding properties of human and rat histamine H3 receptors.Bioorganic & medicinal chemistry letters, , Apr-09, Volume: 11, Issue:7, 2001
Structural modifications in the distal, regulatory region of histamine HEuropean journal of medicinal chemistry, , Mar-05, Volume: 213, 2021
[no title available]Journal of medicinal chemistry, , 06-24, Volume: 64, Issue:12, 2021
Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018).Bioorganic & medicinal chemistry, , 03-15, Volume: 27, Issue:6, 2019
Multi-target-directed-ligands acting as enzyme inhibitors and receptor ligands.European journal of medicinal chemistry, , Oct-15, Volume: 180, 2019
[no title available]European journal of medicinal chemistry, , Mar-25, Volume: 148, 2018
The discovery of the benzazepine class of histamine H3 receptor antagonists.Bioorganic & medicinal chemistry letters, , Dec-15, Volume: 23, Issue:24, 2013
Bodilisant-a novel fluorescent, highly affine histamine h3 receptor ligand.ACS medicinal chemistry letters, , Feb-14, Volume: 4, Issue:2, 2013
Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.Journal of medicinal chemistry, , Mar-08, Volume: 55, Issue:5, 2012
N-Alkenyl and cycloalkyl carbamates as dual acting histamine H3 and H4 receptor ligands.Bioorganic & medicinal chemistry, , May-01, Volume: 19, Issue:9, 2011
Histamine H3 and H4 receptor affinity of branched 3-(1H-imidazol-4-yl)propyl N-alkylcarbamates.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 19, Issue:23, 2009
The alkaloid conessine and analogues as potent histamine H3 receptor antagonists.Journal of medicinal chemistry, , Sep-11, Volume: 51, Issue:17, 2008
4-(2-[2-(2(R)-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and related 2-aminoethylbenzofuran H3 receptor antagonists potently enhance cognition and attention.Journal of medicinal chemistry, , Jan-13, Volume: 48, Issue:1, 2005
2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists.Journal of medicinal chemistry, , Jan-13, Volume: 48, Issue:1, 2005
1-alkyl-4-acylpiperazines as a new class of imidazole-free histamine H(3) receptor antagonists.Journal of medicinal chemistry, , May-20, Volume: 47, Issue:11, 2004
Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.Journal of medicinal chemistry, , Apr-10, Volume: 46, Issue:8, 2003
Different antagonist binding properties of human and rat histamine H3 receptors.Bioorganic & medicinal chemistry letters, , Apr-09, Volume: 11, Issue:7, 2001
4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists.Journal of medicinal chemistry, , May-22, Volume: 51, Issue:10, 2008
Synthesis and SAR of aminoalkoxy-biaryl-4-carboxamides: novel and selective histamine H3 receptor antagonists.Bioorganic & medicinal chemistry letters, , Apr-07, Volume: 13, Issue:7, 2003
A Versatile Sub-Nanomolar Fluorescent Ligand Enables NanoBRET Binding Studies and Single-Molecule Microscopy at the Histamine HJournal of medicinal chemistry, , 08-12, Volume: 64, Issue:15, 2021
Histamine H4 receptor agonists.Bioorganic & medicinal chemistry letters, , Dec-15, Volume: 20, Issue:24, 2010
Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.The Journal of pharmacology and experimental therapeutics, , Volume: 314, Issue:3, 2005
Histamine H4 receptor agonists.Bioorganic & medicinal chemistry letters, , Dec-15, Volume: 20, Issue:24, 2010
A chemical switch for the modulation of the functional activity of higher homologues of histamine on the human histamine H3 receptor: effect of various substitutions at the primary amino function.Journal of medicinal chemistry, , Apr-20, Volume: 49, Issue:8, 2006
Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.The Journal of pharmacology and experimental therapeutics, , Volume: 314, Issue:3, 2005
Synthesis and structure-activity relationships of conformationally constrained histamine H(3) receptor agonists.Journal of medicinal chemistry, , Dec-04, Volume: 46, Issue:25, 2003
Structural modifications in the distal, regulatory region of histamine HEuropean journal of medicinal chemistry, , Mar-05, Volume: 213, 2021
Histamine H3 receptor as a drug discovery target.Journal of medicinal chemistry, , Jan-13, Volume: 54, Issue:1, 2011
Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists.European journal of medicinal chemistry, , Volume: 44, Issue:11, 2009
Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonists.Bioorganic & medicinal chemistry letters, , Dec-15, Volume: 23, Issue:24, 2013
Histamine H3 receptor as a drug discovery target.Journal of medicinal chemistry, , Jan-13, Volume: 54, Issue:1, 2011
Diaryldiamines with dual inhibition of the histamine H(3) receptor and the norepinephrine transporter and the efficacy of 4-(3-(methylamino)-1-phenylpropyl)-6-(2-(pyrrolidin-1-yl)ethoxy)naphthalen-1-ol in pain.Journal of medicinal chemistry, , Nov-11, Volume: 53, Issue:21, 2010
5-hydroxyindole-2-carboxylic acid amides: novel histamine-3 receptor inverse agonists for the treatment of obesity.Journal of medicinal chemistry, , Jul-09, Volume: 52, Issue:13, 2009
Synthesis and evaluation of structurally constrained quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists.Journal of medicinal chemistry, , Nov-13, Volume: 51, Issue:21, 2008
Synthesis and structure-activity relationships of 4,5-fused pyridazinones as histamine H₃ receptor antagonists.Bioorganic & medicinal chemistry letters, , Oct-15, Volume: 21, Issue:20, 2011
Histamine H3 receptor as a drug discovery target.Journal of medicinal chemistry, , Jan-13, Volume: 54, Issue:1, 2011
Novel and highly potent histamine H3 receptor ligands. Part 1: withdrawing of hERG activity.Bioorganic & medicinal chemistry letters, , Sep-15, Volume: 21, Issue:18, 2011
Discovery and characterization of 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, irdabisant): a potent, selective histamine H3 receptor inverse agonist.Journal of medicinal chemistry, , Jul-14, Volume: 54, Issue:13, 2011
In vitro studies on a class of quinoline containing histamine H3 antagonists.Bioorganic & medicinal chemistry letters, , Jun-01, Volume: 20, Issue:11, 2010
5-hydroxyindole-2-carboxylic acid amides: novel histamine-3 receptor inverse agonists for the treatment of obesity.Journal of medicinal chemistry, , Jul-09, Volume: 52, Issue:13, 2009
Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists.European journal of medicinal chemistry, , Volume: 44, Issue:11, 2009
Design of a new histamine H3 receptor antagonist chemotype: (3aR,6aR)-5-alkyl-1-aryl-octahydropyrrolo[3,4-b]pyrroles, synthesis, and structure-activity relationships.Journal of medicinal chemistry, , Aug-13, Volume: 52, Issue:15, 2009
Synthesis and evaluation of structurally constrained quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists.Journal of medicinal chemistry, , Nov-13, Volume: 51, Issue:21, 2008
Refinement of histamine H3 ligands pharmacophore model leads to a new class of potent and selective naphthalene inverse agonists.Bioorganic & medicinal chemistry letters, , Aug-01, Volume: 18, Issue:15, 2008
A new class of histamine H3 receptor antagonists derived from ligand based design.Bioorganic & medicinal chemistry letters, , Jul-01, Volume: 17, Issue:13, 2007
4-[6-(2-Aminoethyl)naphthalen-2-yl]benzonitriles are potent histamine H3 receptor antagonists with high CNS penetration.Bioorganic & medicinal chemistry letters, , Mar-01, Volume: 17, Issue:5, 2007
Synthesis, potency, and in vivo profiles of quinoline containing histamine H3 receptor inverse agonists.Journal of medicinal chemistry, , Nov-01, Volume: 50, Issue:22, 2007
4-(2-[2-(2(R)-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and related 2-aminoethylbenzofuran H3 receptor antagonists potently enhance cognition and attention.Journal of medicinal chemistry, , Jan-13, Volume: 48, Issue:1, 2005
Synthesis and SAR of 5-amino- and 5-(aminomethyl)benzofuran histamine H3 receptor antagonists with improved potency.Journal of medicinal chemistry, , Oct-06, Volume: 48, Issue:20, 2005
A new class of potent non-imidazole H(3) antagonists: 2-aminoethylbenzofurans.Bioorganic & medicinal chemistry letters, , Feb-09, Volume: 14, Issue:3, 2004
Histamine H3 receptor as a drug discovery target.Journal of medicinal chemistry, , Jan-13, Volume: 54, Issue:1, 2011
4-(2-[2-(2(R)-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and related 2-aminoethylbenzofuran H3 receptor antagonists potently enhance cognition and attention.Journal of medicinal chemistry, , Jan-13, Volume: 48, Issue:1, 2005
Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 3: 5-Substituted 3-phenyl-1,2,4-oxadiazoles as potent antagonists.Bioorganic & medicinal chemistry letters, , Feb-09, Volume: 14, Issue:3, 2004
Indole- and benzothiophene-based histamine H3 antagonists.Bioorganic & medicinal chemistry letters, , Nov-01, Volume: 20, Issue:21, 2010
Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists.European journal of medicinal chemistry, , Volume: 44, Issue:11, 2009
Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.European journal of medicinal chemistry, , Volume: 44, Issue:10, 2009
Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.Bioorganic & medicinal chemistry letters, , Sep-01, Volume: 17, Issue:17, 2007
Histamine HBioorganic & medicinal chemistry, , 11-15, Volume: 50, 2021
A Versatile Sub-Nanomolar Fluorescent Ligand Enables NanoBRET Binding Studies and Single-Molecule Microscopy at the Histamine HJournal of medicinal chemistry, , 08-12, Volume: 64, Issue:15, 2021
Structural modifications in the distal, regulatory region of histamine HEuropean journal of medicinal chemistry, , Mar-05, Volume: 213, 2021
New drug approvals for 2019: Synthesis and clinical applications.European journal of medicinal chemistry, , Nov-01, Volume: 205, 2020
Novel pyrrolidinone derivative lacks claimed histamine HEuropean journal of medicinal chemistry, , Apr-01, Volume: 191, 2020
Search for new multi-target compounds against Alzheimer's disease among histamine HEuropean journal of medicinal chemistry, , Jan-01, Volume: 185, 2020
[no title available]European journal of medicinal chemistry, , Dec-01, Volume: 207, 2020
[no title available]Bioorganic & medicinal chemistry, , 05-15, Volume: 26, Issue:9, 2018
Synthesis and biological activity of novel tert-butyl and tert-pentylphenoxyalkyl piperazine derivatives as histamine HEuropean journal of medicinal chemistry, , May-25, Volume: 152, 2018
[no title available]Bioorganic & medicinal chemistry, , 05-15, Volume: 25, Issue:10, 2017
[no title available]Bioorganic & medicinal chemistry, , 10-15, Volume: 25, Issue:20, 2017
Studies on molecular properties prediction and histamine H3 receptor affinities of novel ligands with uracil-based motifs.European journal of medicinal chemistry, , Oct-30, Volume: 86, 2014
Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties.European journal of medicinal chemistry, , Apr-22, Volume: 77, 2014
Azole derivatives as histamine H3 receptor antagonists, part I: thiazol-2-yl ethers.Bioorganic & medicinal chemistry letters, , Oct-01, Volume: 20, Issue:19, 2010
Azole derivatives as histamine H3 receptor antagonists, part 2: C-C and C-S coupled heterocycles.Bioorganic & medicinal chemistry letters, , Oct-01, Volume: 20, Issue:19, 2010
5-hydroxyindole-2-carboxylic acid amides: novel histamine-3 receptor inverse agonists for the treatment of obesity.Journal of medicinal chemistry, , Jul-09, Volume: 52, Issue:13, 2009
Fluorinated non-imidazole histamine H3 receptor antagonists.Bioorganic & medicinal chemistry letters, , Apr-15, Volume: 19, Issue:8, 2009
Diether derivatives of homo- or substituted piperidines as non-imidazole histamine H3 receptor ligands.Bioorganic & medicinal chemistry, , Apr-15, Volume: 17, Issue:8, 2009
Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists.European journal of medicinal chemistry, , Volume: 44, Issue:11, 2009
Piperidine variations in search for non-imidazole histamine H(3) receptor ligands.Bioorganic & medicinal chemistry, , Sep-15, Volume: 16, Issue:18, 2008
Synthesis and evaluation of structurally constrained quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists.Journal of medicinal chemistry, , Nov-13, Volume: 51, Issue:21, 2008
Histamine H4 receptor agonists.Bioorganic & medicinal chemistry letters, , Dec-15, Volume: 20, Issue:24, 2010
Investigation of the histamine H3 receptor binding site. Design and synthesis of hybrid agonists with a lipophilic side chain.Journal of medicinal chemistry, , Sep-09, Volume: 53, Issue:17, 2010
4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists.Journal of medicinal chemistry, , May-22, Volume: 51, Issue:10, 2008
Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.The Journal of pharmacology and experimental therapeutics, , Volume: 314, Issue:3, 2005
Identification of 4-(1H-imidazol-4(5)-ylmethyl)pyridine (immethridine) as a novel, potent, and highly selective histamine H(3) receptor agonist.Journal of medicinal chemistry, , May-06, Volume: 47, Issue:10, 2004
Tactical Approaches to Interconverting GPCR Agonists and Antagonists.Journal of medicinal chemistry, , Feb-11, Volume: 59, Issue:3, 2016
Identification of 4-(1H-imidazol-4(5)-ylmethyl)pyridine (immethridine) as a novel, potent, and highly selective histamine H(3) receptor agonist.Journal of medicinal chemistry, , May-06, Volume: 47, Issue:10, 2004
Synthesis and structure-activity relationships of conformationally constrained histamine H(3) receptor agonists.Journal of medicinal chemistry, , Dec-04, Volume: 46, Issue:25, 2003
Histamine H3 receptor as a drug discovery target.Journal of medicinal chemistry, , Jan-13, Volume: 54, Issue:1, 2011
4-(2-[2-(2(R)-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and related 2-aminoethylbenzofuran H3 receptor antagonists potently enhance cognition and attention.Journal of medicinal chemistry, , Jan-13, Volume: 48, Issue:1, 2005
Synthesis of novel histamine H4 receptor antagonists.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 22, Issue:2, 2012
Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonists.Journal of medicinal chemistry, , Dec-29, Volume: 48, Issue:26, 2005
Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H(4) receptor antagonists.Bioorganic & medicinal chemistry letters, , Nov-01, Volume: 14, Issue:21, 2004
Histamine H4 receptor agonists.Bioorganic & medicinal chemistry letters, , Dec-15, Volume: 20, Issue:24, 2010
4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists.Journal of medicinal chemistry, , May-22, Volume: 51, Issue:10, 2008
Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.The Journal of pharmacology and experimental therapeutics, , Volume: 314, Issue:3, 2005
N-substituted piperidinyl alkyl imidazoles: discovery of methimepip as a potent and selective histamine H3 receptor agonist.Journal of medicinal chemistry, , Mar-24, Volume: 48, Issue:6, 2005
Benzamide derivatives and their constrained analogs as histamine H3 receptor antagonists.European journal of medicinal chemistry, , Jan-27, Volume: 108, 2016
Studies on molecular properties prediction and histamine H3 receptor affinities of novel ligands with uracil-based motifs.European journal of medicinal chemistry, , Oct-30, Volume: 86, 2014
Discovery and characterization of 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, irdabisant): a potent, selective histamine H3 receptor inverse agonist.Journal of medicinal chemistry, , Jul-14, Volume: 54, Issue:13, 2011
Novel and highly potent histamine H3 receptor ligands. Part 1: withdrawing of hERG activity.Bioorganic & medicinal chemistry letters, , Sep-15, Volume: 21, Issue:18, 2011
Synthesis, structure-activity relationships, and biological profiles of a quinazolinone class of histamine H3 receptor inverse agonists.Journal of medicinal chemistry, , Aug-14, Volume: 51, Issue:15, 2008
Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.Journal of medicinal chemistry, , Apr-14, Volume: 59, Issue:7, 2016
Histamine H4 receptor agonists.Bioorganic & medicinal chemistry letters, , Dec-15, Volume: 20, Issue:24, 2010
A chemical switch for the modulation of the functional activity of higher homologues of histamine on the human histamine H3 receptor: effect of various substitutions at the primary amino function.Journal of medicinal chemistry, , Apr-20, Volume: 49, Issue:8, 2006
Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.The Journal of pharmacology and experimental therapeutics, , Volume: 314, Issue:3, 2005
Identification of 4-(1H-imidazol-4(5)-ylmethyl)pyridine (immethridine) as a novel, potent, and highly selective histamine H(3) receptor agonist.Journal of medicinal chemistry, , May-06, Volume: 47, Issue:10, 2004
Synthesis and structure-activity relationships of conformationally constrained histamine H(3) receptor agonists.Journal of medicinal chemistry, , Dec-04, Volume: 46, Issue:25, 2003
The discovery of quinoline based single-ligand human HBioorganic & medicinal chemistry letters, , 12-15, Volume: 26, Issue:24, 2016
Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.Bioorganic & medicinal chemistry, , Oct-15, Volume: 20, Issue:20, 2012
Histamine H3 receptor as a drug discovery target.Journal of medicinal chemistry, , Jan-13, Volume: 54, Issue:1, 2011
The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.Journal of medicinal chemistry, , Apr-14, Volume: 54, Issue:7, 2011
3,4-Diaza-bicyclo[4.1.0]hept-4-en-2-one phenoxypropylamine analogs of irdabisant (CEP-26401) as potent histamine-3 receptor inverse agonists with robust wake-promoting activity.European journal of medicinal chemistry, , May-05, Volume: 95, 2015
Discovery of (1R,6S)-5-[4-(1-cyclobutyl-piperidin-4-yloxy)-phenyl]-3,4-diaza-bicyclo[4.1.0]hept-4-en-2-one (R,S-4a): histamine H(3) receptor inverse agonist demonstrating potent cognitive enhancing and wake promoting activity.Bioorganic & medicinal chemistry letters, , Mar-01, Volume: 24, Issue:5, 2014
Synthesis and structure-activity relationships of 4,5-fused pyridazinones as histamine H₃ receptor antagonists.Bioorganic & medicinal chemistry letters, , Oct-15, Volume: 21, Issue:20, 2011
Identification of pyridazin-3-one derivatives as potent, selective histamine H₃ receptor inverse agonists with robust wake activity.Bioorganic & medicinal chemistry letters, , Sep-15, Volume: 21, Issue:18, 2011
Synthesis and evaluation of pyridazinone-phenethylamine derivatives as selective and orally bioavailable histamine H3 receptor antagonists with robust wake-promoting activity.Bioorganic & medicinal chemistry letters, , Nov-01, Volume: 21, Issue:21, 2011
Discovery and characterization of 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, irdabisant): a potent, selective histamine H3 receptor inverse agonist.Journal of medicinal chemistry, , Jul-14, Volume: 54, Issue:13, 2011
Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.Bioorganic & medicinal chemistry letters, , Feb-01, Volume: 26, Issue:3, 2016
An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.Bioorganic & medicinal chemistry letters, , Jun-01, Volume: 23, Issue:11, 2013
Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 19, Issue:2, 2009
2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists.Journal of medicinal chemistry, , Jan-13, Volume: 48, Issue:1, 2005
Enables
This protein enables 3 target(s):
Target | Category | Definition |
histamine receptor activity | molecular function | Combining with histamine to initiate a change in cell activity. Histamine is a physiologically active amine, found in plant and animal tissue and released from mast cells as part of an allergic reaction in humans. [GOC:ai] |
G protein-coupled acetylcholine receptor activity | molecular function | Combining with acetylcholine and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex. [GOC:bf, GOC:fj, GOC:mah] |
G protein-coupled serotonin receptor activity | molecular function | Combining with the biogenic amine serotonin and transmitting the signal across the membrane by activating an associated G-protein. Serotonin (5-hydroxytryptamine) is a neurotransmitter and hormone found in vertebrates and invertebrates. [GOC:ai] |
Located In
This protein is located in 2 target(s):
Target | Category | Definition |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
presynapse | cellular component | The part of a synapse that is part of the presynaptic cell. [GOC:dos] |
Active In
This protein is active in 3 target(s):
Target | Category | Definition |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
synapse | cellular component | The junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber or a glial cell. As the axon approaches the synapse it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane. [GOC:aruk, ISBN:0198506732, PMID:24619342, PMID:29383328, PMID:31998110] |
dendrite | cellular component | A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body. [GOC:aruk, GOC:bc, GOC:dos, GOC:mah, GOC:nln, ISBN:0198506732] |
Involved In
This protein is involved in 5 target(s):
Target | Category | Definition |
neurotransmitter secretion | biological process | The regulated release of neurotransmitter from the presynapse into the synaptic cleft via calcium-regulated exocytosis during synaptic transmission. [GOC:dph] |
G protein-coupled serotonin receptor signaling pathway | biological process | The series of molecular signals generated as a consequence of a G protein-coupled serotonin receptor binding to one of its physiological ligands. [GOC:mah] |
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | biological process | A G protein-coupled receptor signaling pathway in which the signal is transmitted via the activation or inhibition of a nucleotide cyclase activity and a subsequent change in the concentration of a cyclic nucleotide. [GOC:mah, GOC:signaling, ISBN:0815316194] |
chemical synaptic transmission | biological process | The vesicular release of classical neurotransmitter molecules from a presynapse, across a chemical synapse, the subsequent activation of neurotransmitter receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse. [GOC:jl, MeSH:D009435] |
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway | biological process | An adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway initiated by acetylcholine binding to its receptor, and ending with the regulation of a downstream cellular process. [GOC:dph, GOC:mah, GOC:signaling, GOC:tb] |